- GlobeNewswire•15 hours ago
BRIDGEWATER, N.J., Sept. 27, 2016-- Insmed Incorporated, a global biopharmaceutical company focused on the unmet needs of patients with rare diseases, today announced the appointment of Roger Adsett as ...
- Capital Cube•14 days ago
Categories: Yahoo Finance Get free summary analysis Insmed, Inc. reports financial results for the quarter ended June 30, 2016. Analysis Summary numbers: Revenues of USD 0 million, Net Earnings of USD -36.58 million. The company did not record any revenues for the last twelve months making the comparison of net margin versus asset turnover meaningless. INSM-US‘s earnings and ... Read more (Read more...)
- Accesswire•15 days agoDEADLINE TOMORROW: Lundin Law PC Announces Securities Class Action Lawsuit against Insmed Incorporated and Reminds Investors with Losses to Contact the Firm
LOS ANGELES, CA / ACCESSWIRE / September 12, 2016 / Lundin Law PC (the "Firm") announces a class action lawsuit has been filed against Insmed Incorporated ("Insmed" or the "Company") ...
Insmed Incorporated (INSM)
NasdaqGS - NasdaqGS Real Time Price. Currency in USD
|Bid||7.40 x 1500|
|Day's Range||14.49 - 15.10|
|52wk Range||9.02 - 21.14|
|1y Target Est||N/A|
Trade prices are not sourced from all markets
|P/E Ratio (ttm)||-7.02|
|Avg Vol (3m)||331,876|
|Dividend & Yield||N/A (N/A)|